| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |